phoenix5 logo This is an archived copy of an original page from The Prostate Cancer InfoLink site that went off-line in February, 2001. It is reproduced at Phoenix5 with the permission of Vox Medica.
More Prostate Cancer Pages at Phoenix5             About this archive

logo for prostate cancer infolink
click here to go to Where To Begin? click here to go to Diagnosis men click here to go to Treatment menu click here to go to Support & Help menu click here to go to Home menu

What on Earth is PIN?

Last Revised August 24, 1995
[There may have been developments since this was written.]

Introduction | PIN has many names | So what on Earth is PIN? | How would I know if I had it? | The recommended work-up following a finding of high grade PIN | Can PIN be treated?

Introduction

For many years scientists, pathologists, urologists, and oncologists have been trying to understand what causes prostate cancer. And of course we still don't know. What we do know is that before there is a prostate cancer cell in your prostate there must be something else. In other words, prostate cancer cells do not suddenly spring into existence fully formed and without any sort of explanation.

Many scientists and clinicians are now nearly convinced that before patients get prostate cancer at least some of them get a condition called prostatic intraepithelial neoplasia, commonly abbreviated to PIN. In this section of The Prostate Cancer InfoLink, we will try to explain what PIN is, and perhaps more importantly what you and your doctor should consider doing about it.

PIN has many names

Just as urologists can have heated discussions about exactly how to manage specific cases of prostate cancer, pathologists can have heated discussions about PIN and its significance. One of those heated discussions tends to be about the proper name for this condition.

The term "prostatic intraepithelial neoplasia" or PIN was selected at a conference in 1989 from a whole variety of other names for the same condition. However, human nature being what it is, some of these other names continue in use today. Therefore, any particular urologist or pathologist may use one of the following terms to mean PIN:

  • dysplasia
  • intraductal dysplasia
  • large acinar atypical hyperplasia
  • atypical primary hyperplasia
  • hyperplasia with malignant change
  • marked atypia
  • duct-acinar dysplasia

From the patient's point of view, it doesn't matter what it is called so long as you recognize what it is if your doctor starts to talk about it with you. After you've read through this section, we think you should be reasonably clear about this.

So what on Earth is PIN?

PIN is, in the words on one leading urologist, "the most likely precursor of prostatic adenocarcinoma."

If you imagine that there is a continuous range of identifiable situations related to prostate cancer -- from the very first biochemical event or mutation that leads to the development of the very first malignant prostate cancer cell right through to the extensive growth of bone metastases, then at least some type or types of PIN may well be the first of these situations that a pathologist can actually see under the microscope.

Dr David Bostwick of the Mayo Clinic in Rochester, MN, has suggested that there is a close relationship between the age-related prevalence of PIN and the age-related prevalence of prostate cancer. Figure 1, which has been adapted from material published by Dr Bostwick, clearly indicates that the occurrence of PIN seems to parallel the occurrence of prostate cancer, with prostate cancer lagging about 20 to 30 years behind the appearance of PIN. This suggests that if one carried out prostate cancer screening in younger and younger men, we might find lots of cases of PIN. Then we'd have to decide what to do with them!

sample graph

Figure 1. The relationship between prevalence of PIN and prevalence of prostate cancer.
Adapted from Bostwick DG. "Prostatic intraepithelial neoplasia: diagnostic criteria and clinical significance."
In Issues in the Diagnosis and Prognosis of Prostate Cancer: A Slide/Lecture Series.

PIN is divided into two types or grades: low grade and high grade. However, until just a few years ago it was divided into three grades, so you might still hear your doctors talk about grade I or grade II or grade III PIN. Just in case they do that, you may want to know that today's low grade PIN is roughly the same as the old grades I and II whereas today's high grade PIN is roughly equivalent to the old grade III.

Now we don't think it would help for us to try to get into all of the detailed distinctions between low grade PIN and high grade PIN. It is enough to say that just as pathologists tell one Gleason grade from another on the basis of cell structures and their interrelationships, the same is true for PIN. What is interesting is that we find comparable cellular structures in an early form of breast cancer known as "intraductal carcinoma of the breast."

How would I know if I had it?

PIN can be discovered in exactly the same way as prostate cancer. A man comes in for a check up. He has a DRE and a PSA test. The PSA test comes back positive even though the DRE was negative. The doctor does a six sextant ultrasound-guided biopsy. When the pathologist looks at the biopsy specimen, he or she can find no sign of cancer, but there is a clear occurrence of PIN.

For the physician and the patient, there is only one important question. Now what do I do?

It is worth pointing out that at the moment there is no clear relationship between PSA levels and the occurrence of PIN. Nor are there any indisputable data indicating a clear relationship between the occurrence of PIN and the presence of prostate cancer. However, if the physician is told by the pathologist that there is high grade PIN in the prostate, it is generally agreed at this time that the patient is at risk for prostate cancer.

The recommended work-up following a finding of high grade PIN

First, it should be made very clear that a diagnosis of low grade PIN is not considered to be significant. In other words, if your doctor finds only low grade PIN in the biopsy specimen it is recommended that he just send you home while telling you to come for your next check up a year later.

However, if there is high grade PIN in the biopsy specimen then a number of further steps should be taken:

  • First, the pathologist should examine all of the original biopsy tissue with the greatest care for any traces of prostate cancer tissue.
  • Second, assuming that there is still no trace of prostate cancer, the urologist should give you another PSA test and carry out a second biopsy under TRUS guidance.
  • If cancer is found on the second biopsy, then the patient should be treated accordingly.
  • If there is still no cancer after the second biopsy, your doctor should ask you to come back every 6 months (or four times in the next 2 years) for a repeat ultrasound-guided biopsy and PSA test.
  • If there is still no sign of cancer after 2 years, then your doctor is advised to ask you to return once a year for the next two years for ultrasound-guided biopsy and a PSA test.

The general expectation which is being followed here is that high grade PIN found as a consequence of an elevated PSA is a very close predictor for small foci of localized prostate cancer. Thus, multiple ultrasound-guided biopsies should be carried out over time to ensure the identification of the cancer and appropriate treatment.

Can PIN be treated?

At the moment, there is no evidence that PIN can be successfully treated. However, the idea that PIN might be treatable is very exciting. Some clinical researchers have initiated small studies to examine whether PIN could be reversed with androgen deprivation therapy. Others have wondered whether it could be reversed using a product like finasteride. A third group has suggested the combination of finasteride with a nonsteroidal antiandrogen. At the moment, however, we just do not know enough to say whether PIN can be successfully treated.

Specialists currently recommend that identification of high grade PIN should not in any way affect the treatment of a patient, except that that patient should be regularly rechecked for signs of prostate cancer as discussed above.


Where to Begin?    |    Diagnosis    |    Treatment    |    Support    |    Home Page


The content in this section of the Phoenix 5 site was originally developed by CoMed Communications (a Vox Medica company) as part of The Prostate Cancer InfoLink. It is reproduced here with the permission of Vox Medica.

Go to Phoenix5 Main Menu